ClinicalTrials.gg
RecruitingNCT04007432HIPOXUpdated May 4, 2026

Nocturnal Hypoxia in Geriatric Patients After Hip Fracture

An interventional study of pulse oxymeter in Delirium and Hypoxia, sponsored by Assistance Publique - Hôpitaux de Paris. Recruiting at 2 sites in France. Open to participants aged 70 Years and older. Per ClinicalTrials.gov, last updated 2026-05-04.

Sponsored by Assistance Publique - Hôpitaux de Paris · Not applicable, Interventional, and Diagnostic

From the registry’s dates

  • Started Nov 2020; still recruiting 6 years later.
Phase
Not applicable
Study type
Interventional
Enrollment
70
Allocation
Not applicable
Ages
70 Years and older
Sex
All
01

Study summary

Delirium is a common complication following hip fracture surgery (HFS) in older people. Postoperative hypoxia has also been associated with delirium, but not specifically in geriatric patients. The aim of the study is to demonstrate that post-operative hypoxia is associated with in-hospital complications in patients with HFS.

Read the detailed description

Patients hospitalized in orthogeriatric unit after HFS will be monitored for nocturnal SpO2 with a pulse oximeter continuously during 3 nights. In-hospital complications will be recorded prospectively in all patients, especially the occurrence of delirium with the CAM scale. The hypoxia vs non-hypoxia (more than 20% of the time spent with SpO2\<90%) groups will be analyzed for clinical characteristics, comorbidities and medication use.

The statistical association between severe post-operative nocturnal hypoxemia and occurrence of delirium will be assessed. The dependance between this association and daytime SpO2 will also be assessed. The potential confirmation of an association between post-operative nocturnal hypoxemia in patients with HFS and the occurrence of delirium will lead the reflection on a clinical trial testing the benefit of oxygen therapy in the prevention of post-operative delirium, to improve the medical care of orthogeriatric patients.

02

Conditions studied

  • Delirium
  • Hypoxia

Browse trials for

Keywords

  • nocturnal hypoxia
  • delirum developpement
03

In context

Delirium

933 studies on the registry are indexed under Delirium; 190 are open to participants now.

This study's planned enrollment of 70 is below the median of 112 across 550 interventional studies indexed under Delirium.

Browse Delirium studies →

Lead sponsor

Assistance Publique - Hôpitaux de Paris is the lead sponsor of 3,592 studies on the registry; 1,033 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
70 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • age over 70 years old,
  • hospitalized in orthogeriatrics for hip fracture surgery
  • information about the study and expression of non opposition
  • Expected hospital stay of 5 nights or more

Exclusion criteria

Exclusion Criteria:

  • patient under guardianship,
  • any other type of fracture associated,
  • oxymetry recording not possible (behavioral disorders, night stirring,...)
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
70 participants (estimated)

Study arms

  • Experimental
    Older patients with hip fracture

    Older patients admitted for hip fracture surgery

    Other: pulse oxymeter

Interventions

  • Otherpulse oxymeter

    Nocturnal oxymetry data will be continuously collected during nighttime by a pulse oxymeter, covering for 1 to 3 nights.

06

What researchers measure

Primary outcomes

  1. Delirium

    Delirum or not, diagnosed with CAM (Confusion Assessment Method). Association between nocturnal hypoxia and delirium will be study.

    Time frame: Month 1

Secondary outcomes

  1. In-hospital complications

    Occurrence of in-hospital complications (infection, cardiac, etc). Association between nocturnal hypoxia and others medical complications (infection, cardiac, etc) will be study.

    Time frame: Month 1

  2. Length of hospitalisation stay in othogeriatrics unit

    Length of stay in othogeriatrics unit. Association between nocturnal hypoxia and length of hospitalisation stay in othogeriatrics unit will be study.

    Time frame: Month 1

  3. walking status (functional status)

    walking status (possible with/without help, wheelchair or bedridden) Association between nocturnal hypoxia and functional status will be study.

    Time frame: Month 1

  4. walking status (functional status)

    walking status (possible with/without help, wheelchair or bedridden). Association between nocturnal hypoxia and functional status will be study.

    Time frame: Month 1

  5. walking speed (functional status)

    walking speed for 5 meter. Association between nocturnal hypoxia and functional status will be study.

    Time frame: Month 1

  6. Physical performance (functional status)

    Short Physical Performance Battery (SPPB) is an objective assessment tool for evaluating lower extremity functioning in older persons.

    Time frame: Month 1

  7. Dependency

    Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) are instrument to assess independent living skills. Association between nocturnal hypoxia and independent living skills will be study.

    Time frame: Month 1

  8. Dependency

    Activities of Daily Living (ADL) and Instrumental Activities of Daily Living (IADL) are instrument to assess independent living skills. Association between nocturnal hypoxia and independent living skills will be study.

    Time frame: Month 6

  9. Mortality

    Vital status will be raised

    Time frame: Month 1

  10. Mortality

    Vital status will be raised

    Time frame: Month 6

  11. Nocturnal hypercapnia

    Nocturnal hypercapnia defined by more than 10% time spent with a transcutaneous TcPCO2 ≥50mmHg

    Time frame: Month 1

07

Study locations

2 of 2 sites recruiting
  • Service de gériatrie, Hopital Saint Antoine
    Paris, 75012, France
    Recruiting
  • Service de Gériatrie Hopital de La Pitié Salpetriere
    Paris, 75013, France
    Recruiting
08

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Nov 2020 (actual). Primary completion is estimated for Nov 2028, 96 months after the start.

Of 219 non-industry interventional studies with no phase under Delirium, half reached primary completion within 26 months of starting (the median), counting those still running; a quarter within 12 and three quarters within 45. This study's planned 96 months is above that.

Counting every sponsor, half of 222 studies reached it within 26 months; a quarter within 12 and three quarters within 45.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 18, 2019
First posted
Jul 5, 2019
StartActual
Nov 5, 2020
Primary completionEst.
Nov 5, 2028
CompletionEst.
Nov 5, 2028
Last update
May 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on May 4, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04007432
Responsible party
Sponsor
First posted
Jul 5, 2019
Start date
Nov 5, 2020
Primary completion
Nov 5, 2028 (estimated)
Completion
Nov 5, 2028 (estimated)
Last update
May 4, 2026

Study contacts

Kiyoka KINUGAWA
Contact
kiyoka.kinugawa@aphp.fr
01 49 59 47 53 ext. +33
Kiyoka KINUGAWA
principal investigator · Assistance Publique - Hôpitaux de Paris

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion